Sex differences in benzodiazepine use in the HIV-infected population

References

• Ammassari, A., Murri, R., Pezzotti, P., Trotta, M. P., Ravasio, L., De Longis, P., … Antinori, A. (2001). Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 28, 445–449. doi:10.1097/00042560-200112150-00006
   PubMed Web of Science ®Google Scholar
• Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377–381. doi:10.1007/s11606-002-0044-3
   PubMed Web of Science ®Google Scholar
• Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., … Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366. doi:10.1097/00002030-200003100-00008
   PubMed Web of Science ®Google Scholar
• Bing, E. G., Burman, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., … Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus–infected adults in the United States. Archives of General Psychiatry, 58, 721–728. doi:10.1001/archpsyc.58.8.721
   PubMed Web of Science ®Google Scholar
• Elliott, A. (1998). Anxiety and HIV infection. STEP Perspective, 98, 11–14.
   PubMedGoogle Scholar
• Ferrando, S. J., & Wapenyi, K. (2002). Psychopharmacological treatment of patients with HIV and AIDS. Psychiatric Quarterly, 73(1), 33–49. doi:10.1023/A:1012840717735
   PubMed Web of Science ®Google Scholar
• Greenblatt, D. J., von Moltke, L. L., Harmatz, J. S., Durol, A. L., Daily, J. P., Graf, J. A., … Shader, R. I. (2000). Alprazolam-ritonavir interaction: Implications for product labeling. Clinical Pharmacology & Therapeutics, 67, 335–341. doi:10.1067/mcp.2000.105757
   PubMed Web of Science ®Google Scholar
• Hellinger, F. J., & Encinosa, W. E. (2004). Antiretroviral therapy and health care utilization: A study of privately insured men and women with HIV disease. Health Services Research, 39, 949–968. doi:10.1111/j.1475-6773.2004.00266.x
   PubMed Web of Science ®Google Scholar
• Herek, G. M., Capitanio, J. P., & Widaman, K. F. (2003). Stigma, social risk, and health policy: Public attitudes toward HIV surveillance policies and the social construction of illness. Health Psychology, 22, 533–540. doi:10.1037/0278-6133.22.5.533
   PubMed Web of Science ®Google Scholar
• Karaz, S. S. (2010). Insomnia in psychiatric disorders. In H. P. Attarian & C. Schuman (Eds.), Clinical handbook of insomnia (pp. 229–241). New York, NY: Humana Press.
   Google Scholar
• Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., … Wang, P. S. (2003). The epidemiology of major depressive disorder. The Journal of the American Medical Association, 289, 3095–3105. doi:10.1001/jama.289.23.3095
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R. & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617–627. doi:10.1001/archpsyc.62.6.617
   PubMed Web of Science ®Google Scholar
• Lopes, M., Olfson, M., Rabkin, J., Hasin, D. S., Alegría, A. A., Lin, K. H., … Blanco, C. (2012). Gender, HIV status, and psychiatric disorders: Results from the National Epidemiologic Survey on alcohol and related conditions. The Journal of Clinical Psychiatry, 73, 384–391. doi:10.4088/JCP.10m06304
   PubMed Web of Science ®Google Scholar
• Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squire, C., … Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30. doi:10.7326/0003-4819-133-1-200007040-00004
   PubMed Web of Science ®Google Scholar
• Paulose-Ram, R., Jonas, B. S., Orwig, D., & Safran, M. A. (2004). Prescription psychotropic medication use among the US adult population: Results from the third National Health and Nutrition Examination Survey, 1988–1994. Journal of Clinical Epidemiology, 57, 309–317. doi:10.1016/j.jclinepi.2003.05.001
   PubMed Web of Science ®Google Scholar
• Pence, B. W., Miller, W. C., Whetten, K., Eron, J. J., & Gaynes, B. N. (2006). Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in and HIV clinic in the southeastern United States. Journal of Acquired Immune Deficiency Syndromes, 42, 298–306. doi:10.1097/01.qai.0000219773.82055.aa
   PubMed Web of Science ®Google Scholar
• Roth, T. (2007). Insomnia: Definition, prevalence, etiology, and consequences. Journal of Clinical Sleep Medicine, 3(Suppl. 5), S7–S10.
   PubMed Web of Science ®Google Scholar
• Roux, P., Fugon, L., Michel, L., Lert, F., Obadia, Y., Spire, B., & Carrieri, M. P. (2011). Determinants of benzodiazepine use in a representative population of HIV-infected individuals: The role of HIV status disclosure (ANRS-EN12-VESPA study). AIDS Care, 23, 1163–1170. doi:10.1080/09540121.2011.555738
   PubMed Web of Science ®Google Scholar
• Rubinstein, M. L., & Selwyn, P. A. (1998). High prevalence of insomnia in an outpatient population with HIV infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19, 260–265. doi:10.1097/00042560-199811010-00008
   PubMedGoogle Scholar
• Shader, R. I., Greenblatt, D. J., & Balter, M. B. (1991). Appropriate use and regulatory control of benzodiazepines. The Journal of Clinical Pharmacology, 31, 781–784. doi:10.1002/j.1552-4604.1991.tb01910.x
   PubMedGoogle Scholar
• Singh, N., Squier, C., Sivek, C., Wagener, M., Nguyen, M. H., & Yu, V. L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261–270. doi:10.1080/09540129650125696
   PubMed Web of Science ®Google Scholar
• Valenstein, M., Taylor, K. K., Austin, K., Kales, H. C., McCarthy, J. F., & Blow, F. C. (2004). Benzodiazepine use among depressed patients treated in mental health settings. American Journal of Psychiatry, 161, 654–661. doi:10.1176/appi.ajp.161.4.654
   PubMed Web of Science ®Google Scholar
• Vesga-López, O., Schneier, F. R., Wang, S., Heimberg, R. G., Liu, S.-M., Hasin, D. S., & Blanco, C. (2008). Gender differences in generalized anxiety disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). The Journal of Clinical Psychiatry, 69, 1606–1616. doi:10.4088/JCP.v69n1011
   PubMed Web of Science ®Google Scholar